No Data
No Data
UBS Maintains Align Technology(ALGN.US) With Hold Rating, Cuts Target Price to $230
ALGN Gears Up for Q3 Earnings: What Lies Ahead for the Stock?
Invisalign Palatal Expander System by Align Technology Now Available in Hong Kong for Skeletal and Dental Expansion in Growing Patients
UBS Cuts Align Technology Price Target to $230 From $250, Maintains Neutral Rating
Top Gap Ups and Downs on Friday: TSLA, NVO, WFC and More
Stifel Maintains Align Technology(ALGN.US) With Buy Rating, Cuts Target Price to $285
No Data
No Data